ПРОТЕКТИВНАЯ ЭФФЕКТИВНОСТЬ ПЕРТАКТИН-СОДЕРЖАЩИХ БЕСКЛЕТОЧНЫХ АКДС-ВАКЦИН
Аннотация
Ключевые слова: дети, коклюш, ацеллюлярные АКДС вакцины, пертактин.
(Вопросы современной педиатрии. – 2008; 7(2):77-81)
Об авторах
М.В. ФесенкоРоссия
Л.С. Намазова
Россия
Список литературы
1. Tan T., Trindade E., Skowronski D. Epidemiology of pertussis. Pediatr. Infect. Dis. J. 2005; 24 (5): 10–18.
2. О санитарно-эпидемиологической обстановке в Российской Федерации в 2006 году. Доступно на: www.rospotrebnadzor.ru/docs/doclad.
3. Справка о состоянии инфекционной заболеваемости в Российской Федерации за 6 месяцев 2007 года. Доступно на: www.rospotrebnadzor.ru/sanepid.
4. Diphtheria, tetanus and pertussis: recommendations for vaccine use and other preventive measures recommendations of the Immunization Practices Advisory Committee (ACIP). Morb. Mortal. Wkly. Rep. 1991; 40 (10): 1–28.
5. Edwards K., Decker M. Pertussis vaccine. Plotkin S.A., Orenstein W.A., eds. In: Vaccines. 4th edition. Philadelphia: Saunders. 2004. P. 471–528.
6. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 2005; 18: 326–382.
7. Cherry J.D., Olin P. The science and fiction of pertussis vaccines. Pediatrics. 1999; 104 (6): 1381–1383.
8. Hewlett E.L., Cherry J.D. New and improved vaccines against pertussis. Levine M.M., Woodrow G.C., Kaper J.B., Cobon G.S. eds. In: New Generation Vaccines 2nd ed. New York: Marcel Dekker. 1997. P. 387–416.
9. Cherry J.D. Pertussis. The trials and tribulations of old and new pertussis vaccines. Vaccine. 1992; 10: 1033–1038.
10. Edvards K., Decker M., Mortimer E. Vaccines. Eds. Plotkin S., Orenstein W. Saunders. 1999. P. 293–345.
11. Озерецковский Н.А., Чупринина Р.П. Вакцинопрофилактика коклюша - итоги и перспективы. Вакцинация. 2004; 5 (35): 2–3.
12. Swedish Institute for Infectious Disease Control. Pertussis surveillance in Sweden. October 1997. September 2005. July 2006.
13. URL: www.smittskyddsinstitute.se/upload/Publicationer/SMI-rapport-2006-4.pdf.
14. Leninger E., Roberts M., Kenimer J.G. et al. Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc. Natl. Acad. Sci. USA. 1991; 88 (2): 345–349.
15. Shahin R., Brennan Z., Meade B. et al. Characterization of the protective capacity and immunogenicity of the 69 kD outer membrane protein of Bordetella pertussis. J. Exp. Medicine. 1990; 171: 63–73.
16. Cherry J., Gornbein J., Heininger U. et al. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine. 1998; 16 (20): 1901–1906.
17. Storsaeter J., Hallander H.O., Gustafsson L., Olin P. Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine. 2003; 21 (25-26): 3542–3549.
18. Jefferson T., Rudin M., DiPietrantonj C. Systematic review of the effect of pertussis vaccines in children. Vaccine. 2003; 21 (17-18): 2003–2014.
19. Gustafsson L., Hallander H.O., Olin P. et al. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 1996; 334 (6): 349–355.
20. Greco D., Salmaso S., Mastrantonio P. et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 1996; 334 (6): 341–348.
21. Poolman J.T., Hallander H.O. Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert. Rev. Vaccines. 2007; 6 (1): 47–56.
22. Cherry J.P. Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr. Infect. Dis. J. 1997; 16 (4): 90–96.
23. Edwards K.M., Decker M.D. Acellular pertussis vaccines for infants. NEJM. 1996; 334 (6): 391–392.
24. Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 2000; 49: 1–8.
Рецензия
Для цитирования:
Фесенко М., Намазова Л. ПРОТЕКТИВНАЯ ЭФФЕКТИВНОСТЬ ПЕРТАКТИН-СОДЕРЖАЩИХ БЕСКЛЕТОЧНЫХ АКДС-ВАКЦИН. Вопросы современной педиатрии. 2008;7(2):77-81.
For citation:
Fesenko M., Namazova L. PROTECTIVE EFFICACY OF PERTACTIN CONTAINING ACELLULAR DPT VACCINES. Current Pediatrics. 2008;7(2):77-81.
Послать статью по эл. почте 
